In today’s session Metlife Inc (MET) registered an unusually high (1,128) contracts volume of call trades. Someone, most probably a professional was a very active buyer of the December, 2016 call, expecting serious MET increase. With 1,128 contracts traded and 4404 open interest for the Dec, 16 contract, it seems this is a quite bullish bet. The option with symbol: MET161216C00057500 closed last at: $0.53 or 23.3% up. About 3.87 million shares traded hands. Metlife Inc (NYSE:MET) has risen 19.92% since April 25, 2016 and is uptrending. It has outperformed by 13.90% the S&P500.
Analysts await Metlife Inc (NYSE:MET) to report earnings on February, 1. They expect $1.35 EPS, up 9.76% or $0.12 from last year’s $1.23 per share. MET’s profit will be $1.49B for 10.11 P/E if the $1.35 EPS becomes a reality. After $1.28 actual EPS reported by Metlife Inc for the previous quarter, Wall Street now forecasts 5.47% EPS growth.
Metlife Inc (NYSE:MET) Ratings Coverage
Out of 12 analysts covering MetLife (NYSE:MET), 6 rate it a “Buy”, 0 “Sell”, while 6 “Hold”. This means 50% are positive. MetLife has been the topic of 17 analyst reports since July 31, 2015 according to StockzIntelligence Inc. The rating was maintained by RBC Capital Markets on Tuesday, January 19 with “Outperform”. The rating was upgraded by Sandler O’Neill to “Buy” on Monday, June 27. The firm has “Buy” rating given on Friday, July 31 by Deutsche Bank. The firm has “Mkt Perform” rating by FBR Capital given on Monday, November 28. Deutsche Bank downgraded the shares of MET in a report on Wednesday, July 13 to “Hold” rating. The rating was upgraded by Raymond James to “Strong Buy” on Friday, January 22. The rating was downgraded by Citigroup to “Neutral” on Tuesday, January 5. FBR Capital maintained it with “Outperform” rating and $54 target price in Monday, August 29 report. The company was initiated on Friday, October 7 by Credit Suisse. The stock has “Outperform” rating given by Wells Fargo on Friday, September 23.
According to Zacks Investment Research, “Metlife Inc. is a leading provider of insurance and financial services to a broad spectrum of individual and institutional customers. The company currently provides individual insurance, annuities and investment products. The company also provides group insurance and retirement and savings products and services to corporations and other institutions. The company believes that their unparalleled franchises and brand names uniquely position them to be the preeminent provider of insurance and financial services in the U.S.”
Insitutional Activity: The institutional sentiment decreased to 0.93 in 2016 Q2. Its down 0.11, from 1.04 in 2016Q1. The ratio is negative, as 55 funds sold all Metlife Inc shares owned while 343 reduced positions. 81 funds bought stakes while 334 increased positions. They now own 797.11 million shares or 0.92% less from 804.49 million shares in 2016Q1.
Waverton Investment Limited last reported 61,667 shares in the company. The Idaho-based Selway Asset Mgmt has invested 0.9% in Metlife Inc (NYSE:MET). Budros Ruhlin Roe last reported 0.21% of its portfolio in the stock. Delta Asset Mngmt Lc Tn holds 0% of its portfolio in Metlife Inc (NYSE:MET) for 522 shares. Moreover, Uss Inv Mngmt has 0.58% invested in Metlife Inc (NYSE:MET) for 836,800 shares. Kemper owns 10 shares or 0% of their US portfolio. Spears Abacus Advisors Lc accumulated 676,942 shares or 3.42% of the stock. The Massachusetts-based Adage Capital Prns Grp Inc Limited Liability Corporation has invested 0.07% in Metlife Inc (NYSE:MET). Shinko Asset Communications Limited accumulated 2,472 shares or 0% of the stock. Nomura has 6,203 shares for 0% of their US portfolio. Norinchukin Bancshares The reported 24,096 shares or 0.02% of all its holdings. Ferguson Wellman Cap Mngmt has 258,938 shares for 0.43% of their US portfolio. The Texas-based Dimensional Fund Advisors Limited Partnership has invested 0.13% in Metlife Inc (NYSE:MET). Sei Invests Communication has 0.19% invested in the company for 792,875 shares. Moreover, Argent Capital Llc has 0.52% invested in Metlife Inc (NYSE:MET) for 291,108 shares.
MetLife, Inc. is a provider of life insurance, annuities, employee benefits and asset management. The company has a market cap of $60.14 billion. The Company’s divisions include Retail; Group, Voluntary & Worksite Benefits; Corporate Benefit Funding; Latin America (collectively, the Americas); Asia, and Europe, the Middle East and Africa (EMEA). It has a 16.76 P/E ratio. The Company’s Retail segment is organized into two businesses: Life & Other, and Annuities.
MET Company Profile
MetLife, Inc. (MetLife), incorporated on August 10, 1999, is a well-known provider of life insurance, annuities, employee benefits and asset management. The Company’s divisions include Retail; Group, Voluntary & Worksite Benefits; Corporate Benefit Funding; Latin America (collectively, the Americas); Asia, and Europe, the Middle East and Africa (EMEA). In addition, MetLife’s Corporate & Other contains the surplus portfolios for the enterprise, the portfolios used to fund the capital needs of the Company and various reinsurance agreements. In the United States, the Company provides a range of insurance and financial services products, including life, dental, disability, property and casualty, guaranteed interest, stable value and annuities, through both proprietary and independent retail distribution channels, as well as at the workplace. Outside the United States, the Company provides life, medical, dental, credit and other accident and health insurance, as well as annuities, endowment and retirement and savings products to both individuals and groups.
More news for Metlife Inc (NYSE:MET) were recently published by: Investorplace.com, which released: “Metlife Inc (MET) Is Starting Its Run” on November 17, 2016. Investorplace.com‘s article titled: “Trade of the Day: Metlife Inc (MET) Stock Will Fly Past Estimates” and published on October 31, 2016 is yet another important article.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.